TY - JOUR
T1 - Oxygen Availability and Metabolic Dynamics During Mycobacterium tuberculosis Latency
AU - May, Elebeoba E.
AU - Sershen, Cheryl L.
N1 - Publisher Copyright:
© 1964-2012 IEEE.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/10
Y1 - 2016/10
N2 - Objective: In vitro models of Mycobacterium tuberculosis (Mtb) nonreplicating persistence (NRP) suggest the rate of oxygen (O2) depletion is a significant determinant in persistence. However, few studies have characterized the metabolic association between slow and rapid O2 depletion rates and successful versus failed persistence. Methods: We developed a theoretical model of Mtb metabolic adaptation that includes O2 driven genetic modulation of enzymes in the tricarboxylic acid cycle, energy, and redox recycling pathways. We conducted an in silico study of Mtb adaptation, and investigated the metabolic dynamics that enable persistence during slow versus rapid anaerobiosis. Results: Consistent with in vitro studies, during rapid anaerobiosis the most significant enzymatic changes occurred during the active growth period while the majority of the slow anaerobic system's adaptive response occurred during the first phase of aerobic shiftdown (NRP1). The characteristic response of the two conditions differed, with the slow anaerobic system exhibiting positive adaptation response, upregulating six enzymes during NRP1, while the rapid system exhibited a negative adaptation response, decreasing the levels of seven enzymes during active growth. Conclusion: Results of our study illustrate the intricate metabolic balance Mtb achieves during adaptation to anaerobic conditions, and how failure in redox recycling correlates to failure in persistence. Significance: We have provided the first theoretical description of the genetic and metabolic death profile for Mtb during anaerobic growth. Insight into Mtbs dynamic adaptation response provides a unique systems framework for the development of targeted therapies to reduce the likelihood of mycobacterial persistence and the related incidence of latent tuberculosis infection.
AB - Objective: In vitro models of Mycobacterium tuberculosis (Mtb) nonreplicating persistence (NRP) suggest the rate of oxygen (O2) depletion is a significant determinant in persistence. However, few studies have characterized the metabolic association between slow and rapid O2 depletion rates and successful versus failed persistence. Methods: We developed a theoretical model of Mtb metabolic adaptation that includes O2 driven genetic modulation of enzymes in the tricarboxylic acid cycle, energy, and redox recycling pathways. We conducted an in silico study of Mtb adaptation, and investigated the metabolic dynamics that enable persistence during slow versus rapid anaerobiosis. Results: Consistent with in vitro studies, during rapid anaerobiosis the most significant enzymatic changes occurred during the active growth period while the majority of the slow anaerobic system's adaptive response occurred during the first phase of aerobic shiftdown (NRP1). The characteristic response of the two conditions differed, with the slow anaerobic system exhibiting positive adaptation response, upregulating six enzymes during NRP1, while the rapid system exhibited a negative adaptation response, decreasing the levels of seven enzymes during active growth. Conclusion: Results of our study illustrate the intricate metabolic balance Mtb achieves during adaptation to anaerobic conditions, and how failure in redox recycling correlates to failure in persistence. Significance: We have provided the first theoretical description of the genetic and metabolic death profile for Mtb during anaerobic growth. Insight into Mtbs dynamic adaptation response provides a unique systems framework for the development of targeted therapies to reduce the likelihood of mycobacterial persistence and the related incidence of latent tuberculosis infection.
KW - Computational systems biology
KW - pathology
UR - http://www.scopus.com/inward/record.url?scp=85027048405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027048405&partnerID=8YFLogxK
U2 - 10.1109/TBME.2016.2605701
DO - 10.1109/TBME.2016.2605701
M3 - Article
C2 - 27608448
AN - SCOPUS:85027048405
VL - 63
SP - 2036
EP - 2046
JO - IEEE Transactions on Biomedical Engineering
JF - IEEE Transactions on Biomedical Engineering
SN - 0018-9294
IS - 10
M1 - 7559795
ER -